ArticleBMC psychiatry2026
Effectiveness and patient experience of a day rehabilitation ward in China: a mixed-methods study.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThis study explored the objective effectiveness of treatment and the subjective experiences of patients with schizophrenia spectrum disorders (SSD) and mood disorders (MD) in a day rehabilitation ward.
methodsA mixed-methods design was employed. Patients meeting the ICD-10 criteria for SSD or MD were enrolled. Standardised scales (BPRS, HAMD, MRSS) were used to assess symptom and functional changes in 377 patients; semi-structured interviews were conducted with 27 purposively sampled patients, and the data were analyzed using content analysis.
resultsQuantitative findings showed that, after treatment, patients with SSD had significantly lower BPRS total scores (Z=-2.929, P = 0.003), including lower factor scores for hostile suspiciousness (Z=-3.225, P = 0.001) and thought disturbance (Z=-2.412, P = 0.016). The MRSS total score (Z=-2.031, P = 0.042) and dependency subscale score (Z=-2.045, P = 0.041) were also significantly lower. For patients with MD, HAMD total score (Z=-4.188, P < 0.001) and the factor scores for anxiety/somatisation (Z=-3.604, P < 0.001), cognitive disturbance (Z=-3.385, P < 0.001), retardation (Z=-4.208, P < 0.001), sleep disturbance (Z=-2.842, P = 0.004), and hopelessness (Z=-2.448, P = 0.014) were significantly reduced. MRSS total score (Z=-2.294, P = 0.022) and inactivity subscale score(Z=-2.276, P = 0.023) were likewise significantly lower. Qualitative findings indicated that patients perceived positive changes in symptoms and illness status, personal growth, interpersonal communication, life fulfillment, and social integration. Reported challenges included difficulty in keeping up with and integrating into the courses, rehabilitation plateaus, and insufficient social support.
conclusionOur findings suggest that patients with both SSD and MD experienced symptomatic improvement after treatment in the day rehabilitation ward. Changes in social functioning require further investigation. In addition, patients continued to face difficulties and challenges during day treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.